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PURPOSE: To evaluate the functional activity of the classical and alternative pathways of the complement system and
the levels of C3, C4, and factor B during the first episode of meningococcal infection and during the convalescence period.
PATIENTS AND METHODS: Ten Brazilian children ranging in age from 8 months to 8 years, admitted from 1991 to
1993 with a clinical-laboratory diagnosis of meningococcal meningitis, were studied during acute infection (up to 7 days
from diagnosis) and during the convalescence period (1 to 6 months after the acute episode). C3, C4, and Factor B were
measured using nephelometry, and the lytic activity of classical and alternative pathways were evaluated by a kinetic
method and expressed as the time needed to lyse 50% of an erythrocyte suspension (T1/2, expressed in seconds). Low T1/
2 values for classical and alternative pathways correlate with high activities of the classical and alternative complement
pathways, respectively.
RESULTS: A significant difference was observed between the alternative pathway lytic activity during infection and
the convalescence period (282 vs 238 seconds, respectively, P = .01). No differences were detected in the other complement
parameters analyzed.
CONCLUSIONS: In the presence of meningococcal meningitis, the alternative pathway is preferentially activated.
This is probably due to the greater ability of the meningococcal endotoxin to activate this pathway in vivo.
KEYWORDS: Complement. Classical pathway. Alternative pathway. Lytic activity. Meningococcal meningitis.
Activation of complement by gram-negative bacteria can
occur via the classical (CP) or the alternative pathway (AP).1
Complement levels are often abnormal in patients with an
acute meningococcal infection.2 Activation of the CP or low
levels of C3 during meningococcal meningitis have been
reported in different countries including Nigeria3, Brazil,4
and the United States.5 Moreover, a significant depression
in functional activity of the CP and of C3 and factor B lev-
els has been reported in children with severe meningococ-
cal infection, suggesting that activation of both the CP and
the AP occurs in this particular setting.2 Activation of AP
in patients with gram-negative bacteriemia and shock has
been demonstrated.6 In the present study, we measured the
lytic activity of the CP and AP, as well as the levels of C3,
C4, and factor B in Brazilian children during and after the
first episode of meningococcal meningitis in order to as-
sess the activation of both complement pathways in this
disease.
METHODS
All procedures were in accordance with the ethical
standards of the institutional committee on human experi-
mentation. Ten consecutive patients with ages ranging from
8 months to 8 years with acute meningococcal meningitis
were studied during the acute infection phase (up to 7 days
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from diagnosis) and during the convalescence period (be-
tween 1 and 6 months after the cure). The inclusion criteria
were clinical signs of meningococcal infection, absence of
autoimmunity and other infectious diseases, and normal
nutritional status. All of the participants were from Ribeirão
Preto and were diagnosed between 1991 and 1993. The di-
agnosis of meningococcal infection was based on clinical
signs and confirmed by bacteriologic exams. Blood sam-
ples were collected by venipuncture from patients and left
to clot at room temperature for 90 minutes. Serum was ob-
tained by centrifugation at 4ºC, pooled, sampled, frozen in
liquid nitrogen, and stored at -70ºC until analysis in 1994.
The lytic complement activity of CP and AP was measured
by means of a kinetic assay, as previously described, with
minor modifications.7,8 Briefly, the time required to lyse
50% of an erythrocyte suspension was measured (T1/2).
Low T1/2 values for CP and AP correlate with high CP and
AP complement activities, respectively. For the CP assay, a
suspension of sensitized sheep red blood cells (SRBC) in
triethanolamine-buffered saline containing 0.1% gelatin,
0.5 mM Mg++, and 0.15 mM Ca++ (TBS Mg++ Ca++) was
standardized at concentrations sufficient to reach an opti-
cal density of 1.5 units at 700 nm when mixed with the
diluted serum sample. For the AP assay, uncoated rabbit
erythrocytes (RaBC) in triethanolamine-buffered saline con-
taining 0.1% gelatin, 2 mM Mg++, and 8 mM ethylene-gly-
col-bis (b-aminoethyl ether) N, N, N’, N’, -tetraacetic acid
(TBS-Mg++EGTA) were standardized as described for the
sheep erythrocytes. The final serum dilution of the samples
was 1:38 for the CP and 1:6 for the AP experiments. The
concentrations of C3, C4, and factor B were assayed by ki-
netic nephelometry with an Immunochemistry Analyzer ICS
II (Beckman Instruments Inc. Diagnostic System Group,
Galway, Ireland).
Statistical analysis using the Student paired t test was
performed to compare complement levels during infection
and the convalescence period.
RESULTS
The individual values obtained for CP lytic activity dur-
ing the acute phase of meningitis and after infection were
within the normal estimated range for age-matched Brazil-
ian children. No significant differences were found between
the arithmetic means of CP activity during (143 seconds)
and after (149 seconds) meningococcal meningitis (Table
1). On the other hand, 3 out of 10 children studied (30%)
had higher AP T1/2 values during acute meningitis than
the upper limit estimated for their age, indicating a lower
AP activity in these children (Table 2). One child main-
tained high AP T1/2 times during the convalescence period.
Unfortunately, we could not contact this child afterwards
to complete the investigation. The AP activity during acute
infection was significantly lower compared to that observed
after infection (Table 2). Concentrations of C3, C4, and fac-
tor B during the acute phase were higher than the upper
limit of age-matched Brazilian children in 66.7%, 44.5%,
and 55.5% of the patients, respectively (data not shown).
No significant differences were found in the levels of C3,
C4, or factor B during or after meningitis.
DISCUSSION
Systemic inflammation by activated complement and
cytokines is important in the pathogenesis of
meningoccocal disease.9
Our results suggest that AP activation occurs during
acute meningococcal meningitis, since we have observed
Table 1 - Classical pathway (CP) hemolytic activity, expressed as T1/2 (in seconds), during and after meningococcal
meningitis.
Patients Age Reference values*(seconds) CP (T1/2 in seconds)
Infection Convalescence
1 8 months 108-255 193 170
2 10 months+ 108-255 198 127
3 1 year 108-255 127 201
4 2 years 121-218 120 105
5 4 years 104-300 140 133
6 4 years 104-300 89 120
7 3 years+ 104-300 128 147
8 8 years+ 107-306 155 184
9 2 years 121-218 116 120
10 8 years 107-306 161 180
Mean 143† 149
(*) Reference values according to age as established by Ferriani, Barbosa & Carvalho.7
(+) Children with meningococcemia
(†) P = .44
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significantly decreased AP hemolytic activity in the acute
phase of this infection, as compared to the convalescence
period. This is in accordance with the known ability of the
meningococcal endotoxin to activate the AP in vivo.10 We
did not find evidence of activation of the CP in these pa-
tients, since the T1/2 times were similar for both periods.
In another Brazilian study, investigators used the CH50 as-
say for total complement (CH50 levels) and an assay for
C3 levels in 25 patients, including 8 children, with menin-
gococcal meningitis.4 Although they reported significantly
reduced CH50 levels in the patients when compared to nor-
mal adults, all 8 children studied presented CH50 levels
within the normal range for adults. These results are not in
accordance with those reported in yet another study,2 in
which normal AP50 and decreased CH50 levels in children
with meningococcal infection compared to normal adults
was found. However, these investigators did not compare
the values during and after the infection. They also found
significantly lower complement levels, particularly regard-
ing the CH50 assay, C3, and factor B, in more severely af-
fected children, including those who developed septicemia.
In a case report, 36-year-old patient with meningoccocal
meningitis had undetectable levels of C7 and total com-
plement as revealed by the CH50 assay. So it appears that
the best screen for complement deficiencies or significant
activation is the CH50 assay.11 Complete non-response in
the CH50 assay associated with normal C3 levels is a strong
indication for complement deficiency and should be fol-
lowed up with further tests.12 In spite of our limited number
of cases, it is worth mentioning that 3 out of 10 children
studied presented meningococcemia, and their AP and CP
activity levels were not different from those estimated for
normal age-matched Brazilian children. One of the patients
(# 6) maintained a higher than normal AP T1/2 during the
convalescence period. Since we were not able to contact
this patient afterwards, we could not establish whether this
child presented a transient alteration or a partial deficiency
of properdin or of factor D. Properdin deficiency has been
associated with severe meningoccocal disease. In a study
in 3 generations of a large Swiss family, the concentration
of circulating properdin in affected males was <0.1 mg/L,
indicating properdin deficiency type I, and 2 of the 9
properdin-deficient males in the family had survived men-
ingitis caused by Neisseria meningitidis serogroup B with-
out sequelae.13
No significant differences occurred between the mean
levels of C3, C4, and factor B during and after meningococ-
cal meningitis. Some of the children showed a non-signifi-
cant trend towards increased levels of factor B, C3, and C4
as compared to normal controls, suggesting that these com-
ponents were acting as acute phase proteins, as previously
reported in many infectious conditions.14 These results sug-
gest that in the presence of an infectious episode, the alter-
native pathway is preferentially activated, probably due to
the greater capacity of the meningococcal endotoxin to ac-
tivate this pathway in vivo. The assessment of properdin lev-
els and of more sensitive markers of complement activation,
such as C3a, C3d, C5a, Ba, and soluble C5b-9 complex dur-
ing and after meningococcal infection are needed to better
understand the role of complement in meningitis.
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Table 2 - Alternative pathway (AP) hemolytic activity, expressed as T1/2 (in seconds), during and after menigococcal
meningitis.
Patients Age Reference values*(seconds) AP (T1/2 in seconds)
Infection Convalescence
1 8 months 172-305 374 252
2 10 months+ 172-305 297 257
3 1 year 172-305 275 173
4 2 years 184-273 321 240
5 4 years 177-301 225 200
6 4 years 177-301 339 336
7 3 years+ 177-301 243 249
8 8 years+ 171-274 248 238
9 2 years 184-273 239 204
10 8 years 171-274 261 228
Mean 282† 238
(*) Reference values according to age as established by Ferriani, Barbosa & Carvalho.7
(+) Children with meningococcemia
(†) P = .01
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RESUMO
ROXO Jr. P e col. Níveis de complemento em crianças bra-
sileiras durante e após meningite meningocócica.
CLINICS 60(2):127-130, 2005.
OBJETIVO: Avaliar a atividade funcional das vias clás-
sica e alternativa do sistema complemento e os níveis de
C3, C4 e fator B durante o primeiro episódio de infecção
meningocócica e durante a convalescença.
PACIENTES E MÉTODOS: Dez crianças brasileiras
com idades entre 8 meses e 8 anos, admitidas de 1991 a
1993, com diagnóstico clínico-laboratorial de meningite
meningocócica, foram estudadas durante infecção aguda
(até 7 dias do diagnóstico) e no período de convalescença
(entre 1 e 6 meses após). C3, C4 e fator B foram quanti-
ficados por nefelometria e a atividade lítica das vias clássi-
ca e alternativa foi avaliada por método cinético e expres-
sa como tempo necessário para lisar 50% de uma suspen-
são de eritrócitos (T1/2, expresso em segundos). Baixos va-
lores de T1/2 das vias clássica e alternativa se correlacionam
com elevadas atividades de via clássica e via alternativa,
respectivamente.
RESULTADOS: Observaram-se diferenças significativas
entre a atividade lítica da via alternativa durante a infec-
ção e no período de convalescença (282 e 238 segundos,
respectivamente, P= .01). Nenhuma diferença foi detectada
nos outros parâmetros analisados.
CONCLUSÕES: Na presença de meningite menin-
gocócica a via alternativa é preferencialmente ativada, pro-
vavelmente devido à maior capacidade da endotoxina
meningocócica para ativar esta via, in vivo.
UNITERMOS: Complemento. Via clássica. Via alter-
nativa. Atividade lítica. Meningite meningocócica.
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